December 20, 2022
Cellphire Therapeutics Issued New Core Technology Patent (Materials and Methods for Producing Blood Products)
Cellphire Therapeutics is excited to announce the United States Patent Office (USPTO) issued a patent, entitled Materials and Methods for Manufacturing Blood Products (Patent 11,529,587 B2 ('587 Patent) covering a new innovation in the method used to produce Thrombosomes®.